EquitAI LogoEquitAI
$155.64
-1.71%
NBIX

NBIX

Neurocrine Biosciences, Inc.

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
5/10
Quality
9/10
Growth
9/10
Strength
7/10
Dividend
1/10
Price Trend
Upwards
Momentum
Neutral
Balance Sheet
Healthy
Earnings
Growth
Dividend Yield
0.00%
Market Cap
$15.82B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Neurocrine Biosciences discovers and develops specialized medicines for neurological, psychiatric, and endocrine disorders. Its primary focus is creating highly targeted treatments for underserved patient populations suffering from complex movement and hormonal conditions. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...